# Revero

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/revero

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.revero.com
- Total disclosed funding: $5M
- Latest round: Seed (Nov 3, 2022)
- Investors on record: 4

## About

Based in California, US, and founded in 2019 by its CEO Mahsa Rostami and co-founder Shawn Baker, Revero Inc. operates as an AI digital health company that helps patients treat autoimmune and other medical disorders. In November 2022, Revero Inc raised USD 5 million in seed funding from a16z, CapitalX, Goodwater Capital, and Think + Ventures. As of November 2022, the company has nearly 3,000 paying subscribers.

Revero Inc. develops a virtual clinic that integrates nutritional therapy machine learning, continuous personalized care, and digital tools to address a broader range of metabolic conditions such as type-2 diabetes, heart disease, arthritis, psoriasis, Crohn’s Disease, and even mental health issues, including anxiety and depression. With the help of AI-based medical nutritional therapy platform enables eliminates the foods that are contributing to the pathways of disease and provides personalized treatment based on biomarkers and clinical outcomes.

The company generates revenue through its subscription-based model.

The company plans to use the seed funding to focus on business expansion across the US in all 50 states.

## Funding rounds

- Seed, Nov 3, 2022, $5M — Andreessen Horowitz, Think + Ventures, Goodwater Capital, CapitalX

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed
- Think + Ventures (https://capitalatlas.ai/funds/think-ventures) — Seed
- Goodwater Capital (https://capitalatlas.ai/funds/goodwater-capital) — Seed
- CapitalX (https://capitalatlas.ai/funds/capitalx) — Seed